Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term fospropofol vs propofol and lipid metabolism in hyperlipidemia
ChiCTR2400088910Phase 4Not yet recruiting
- Sponsor
- Guangyuan First People's Hospital
- Start
- Aug 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fospropofol disodium in hyperlipidemia (2 arms), sponsored by Guangyuan First People's Hospital. Primary endpoints: Triglyceride, Total cholesterol and 4 more. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
fospropofol disodium
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on ChiCTR2400088910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088910.